khusinol
isolongifolan-7-alpha-ol
Identification
| Name | khusinol |
| CAS Number | 24268-34-6 |
| FDA UNII | Search |
| Molecular Formula | C15 H24 O |
| Molecular Weight | 220.35548000 |
| Nikkaji Number | J16.396A |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | natural substances and extractives |
| Recommendation for khusinol usage levels up to | not for fragrance use. |
| Recommendation for khusinol flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
iso
longifolan-7-alpha-ol
iso
longifolol
PubMed:
Chemical composition, antinociceptive and anti-inflammatory properties of essential oil from the roots of Illicium lanceolatum.
PubMed:
Essential oil from aerial parts of of Betonica grandiflora Willd. from Iran.
PubMed:
Microbial transformation of (-)-isolongifolol by plant pathogenic fungus Glomerella cingulata.
PubMed:
Terpene conjugates of diaminedichloridoplatinum(II) complexes: antiproliferative effects in HL-60 leukemia, 518A2 melanoma, and HT-29 colon cancer cells.
PubMed:
Stereochemical and steric control of the UDP-glucuronosyltransferase-catalyzed conjugation reaction: a rational approach for the design of inhibitors for the human UGT2B7.
PubMed:
Eudismic analysis of tricyclic sesquiterpenoid alcohols: lead structures for the design of potent inhibitors of the human UDP-glucuronosyltransferase 2B7.
PubMed:
Biotransformation of (+)-cycloisolongifolol by plant pathogenic fungus Glomerella cingulata.
PubMed:
Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives.
PubMed:
Microbial transformation of (-)-isolongifolol and butyrylcholinesterase inhibitory activity of transformed products.